Predicting Intracerebral Hemorrhage Outcomes With Peak Perihemorrhagic Edema
Further research may be necessary to better understand the pathophysiologic mechanisms involved in perihemorrhagic edema evolution and ICH.
Intracerebral Hemorrhage
Stroke, ICH Risk Elevated in Seniors With AFib Taking Anticoagulants
For patients with CKD and atrial fibrillation, anticoagulants are linked with an increased risk of ischemic stroke.
Intracerebral Hemorrhage-Related Hospital Mortality Reduced With Prior NOAC Use
Outcomes in intracerebral hemorrhage are less severe in patients with prior NOAC use.
ENCHANTED Update: No Role for Low-Dose Alteplase After All?
Results from a secondary analysis of the ENCHANTED trial add to a pile of weak data that likely will not affect clinical practice.
Noncontrast CT Markers Predict Hematoma Growth Risk in Hemorrhagic Stroke
Surprisingly, no evidence was found to suggest that patients with these markers benefit from intensive blood pressure reduction.
After Stroke, Intensive Antiplatelet Therapy Has Benefits, Drawbacks
Intensive antiplatelet therapy appears to reduce risk of recurrence immediately after stroke, but may pose risks further out.
Intracerebral Hemorrhage Outcomes Improved With Anticoagulants
Resumption of oral anticoagulants after intracerebral hemorrhage was found to improve outcomes at 1 year.
In Intracerebral Hemorrhage, Intensive BP Lowering Has Little Impact on Outcomes
The investigators reported no difference in 3-month mortality rates across all 5 studies included in the meta-analysis.
Oral Anticoagulation After ICH: Risks and Outcomes
Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.
Medical Complications After ICH: Changes in the Last Decade
As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.
- Loading...
Loading...
Next post in International Stroke Conference 2017
Loading... 
Loading...